EDIT logo

Editas Medicine (EDIT)

Profile

Full Name

Editas Medicine, Inc.

Ticker Symbol

EDIT

Exchange

NASDAQ

Country

United States

IPO

February 3, 2016

Indexes

Not included

Employees

246

Key Details

Price

$1.35(+2.27%)

Market cap

$112.02M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$32.31M(-58.64% YoY)

Annual EPS

-$2.88(-42.57% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Dec 16, 24 JP Morgan
Underweight
Dec 16, 24 Evercore ISI Group
Outperform
Dec 13, 24 Stifel
Hold
Dec 13, 24 RBC Capital
Sector Perform
Dec 13, 24 Chardan Capital
Neutral
Dec 13, 24 Barclays
Equal-Weight
Dec 13, 24 Baird
Outperform
Dec 11, 24 Wells Fargo
Equal-Weight
Nov 5, 24 Wells Fargo
Overweight
Nov 5, 24 Truist Securities
Buy

Institutional Ownership

  • What is the ticker symbol for Editas Medicine?
  • Does Editas Medicine pay dividends?
  • What sector is Editas Medicine in?
  • What industry is Editas Medicine in?
  • What country is Editas Medicine based in?
  • When did Editas Medicine go public?
  • Is Editas Medicine in the S&P 500?
  • Is Editas Medicine in the NASDAQ 100?
  • Is Editas Medicine in the Dow Jones?
  • When was Editas Medicine's last earnings report?
  • When does Editas Medicine report earnings?
  • Should I buy Editas Medicine stock now?

What is the ticker symbol for Editas Medicine?

The ticker symbol for Editas Medicine is NASDAQ:EDIT

Does Editas Medicine pay dividends?

No, Editas Medicine does not pay dividends

What sector is Editas Medicine in?

Editas Medicine is in the Healthcare sector

What industry is Editas Medicine in?

Editas Medicine is in the Biotechnology industry

What country is Editas Medicine based in?

Editas Medicine is headquartered in United States

When did Editas Medicine go public?

Editas Medicine's initial public offering (IPO) was on February 3, 2016

Is Editas Medicine in the S&P 500?

No, Editas Medicine is not included in the S&P 500 index

Is Editas Medicine in the NASDAQ 100?

No, Editas Medicine is not included in the NASDAQ 100 index

Is Editas Medicine in the Dow Jones?

No, Editas Medicine is not included in the Dow Jones index

When was Editas Medicine's last earnings report?

Editas Medicine's most recent earnings report was on Mar 5, 2025

When does Editas Medicine report earnings?

The next expected earnings date for Editas Medicine is May 8, 2025

Should I buy Editas Medicine stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page